According to recent monitoring data, China recorded 1,060,600 new cases of lung cancer in 2022, accounting for 22% of all malignant tumors.

Chinese authorities have intensified efforts to prevent the import of the mpox virus as global cases continue to rise.

In some areas with weak medical resources in China, it is difficult for the public to obtain quality medical services and have to seek treatment across provinces and regions, which is a heavy economic and time burden.

On June 28, the National Health Commission of the PRC released the "COVID-19 Prevention and Control Plan (Ninth Edition)". Compared with the eighth edition, the following revisions were made:

A few days ago, the Department of Planning, Development and Information Technology of the China National Health and Medical Commission issued the "Notice of the Office of the Healthy China Action Promotion Committee on Printing and Distributing the Work Points of the Healthy China Action in 2022".